Financial reports
10-K
2017 FY
Annual report
30 Mar 18
10-Q
2017 Q3
Quarterly report
13 Nov 17
10-Q
2017 Q2
Quarterly report
11 Aug 17
10-Q
2017 Q1
Quarterly report
12 May 17
10-K
2016 FY
Annual report
30 Mar 17
10-Q
2016 Q3
Quarterly report
14 Nov 16
10-Q
2016 Q2
Quarterly report
15 Aug 16
10-Q
2016 Q1
Quarterly report
16 May 16
10-KT
Annual report (with FYE transition)
29 Mar 16
10-Q
2016 Q2
Quarterly report
12 Nov 15
Current reports
8-K
Completion of Acquisition or Disposition of Assets
24 Apr 18
8-K
Tender and Support Agreement
12 Mar 18
8-K
Cogentix Medical Announces 17% Preliminary Fourth Quarter 2017 Year-Over-Year Revenue Growth
6 Feb 18
8-K
Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company History
7 Nov 17
8-K
Results of Operations and Financial Condition
1 Aug 17
8-K
Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018
18 Jul 17
8-K
Submission of Matters to a Vote of Security Holders
6 Jun 17
8-K
Departure of Directors or Certain Officers
25 May 17
8-K
Cogentix Medical Reports First Quarter Operating Results; Urology Revenue Up 11 Percent
2 May 17
8-K
Entry into a Material Definitive Agreement
24 Mar 17
Registration and prospectus
15-12G
Securities registration termination
3 May 18
POS AM
Prospectus update (post-effective amendment)
30 Apr 18
POS AM
Prospectus update (post-effective amendment)
30 Apr 18
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Apr 18
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Apr 18
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Apr 18
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Apr 18
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Apr 18
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Apr 18
25-NSE
Exchange delisting
23 Apr 18
Proxies
DEF 14A
Definitive proxy
25 Apr 17
PRER14A
Preliminary revised proxy
14 Apr 17
PRE 14A
Preliminary proxy
7 Apr 17
DEF 14A
Definitive proxy
11 Oct 16
PRE 14A
Preliminary proxy
27 Sep 16
DEFA14A
Additional proxy soliciting materials
26 Sep 16
DEFA14A
Additional proxy soliciting materials
7 Sep 16
DFAN14A
Additional proxy materials by non-management
13 May 16
DEFA14A
Additional proxy soliciting materials
9 May 16
DEFA14A
Additional proxy soliciting materials
9 May 16
Other
EFFECT
Notice of effectiveness
16 May 18
EFFECT
Notice of effectiveness
16 May 18
SD
Conflict minerals disclosure
31 May 17
CT ORDER
Confidential treatment order
23 May 17
UPLOAD
Letter from SEC
11 May 17
EFFECT
Notice of effectiveness
4 May 17
CORRESP
Correspondence with SEC
3 May 17
UPLOAD
Letter from SEC
17 Apr 17
SD
Conflict minerals disclosure
1 Jun 16
UPLOAD
Letter from SEC
19 Apr 16